SareptAssist Patient Assistance Program

Funded
About
The SareptAssist Patient Assistance Program offers vital support for patients prescribed Exondys 51, Vyondys 53, Amondys 45, and Elevidys. This program is specifically designed to help uninsured or underinsured patients by providing them access to necessary medications. By ensuring that patients with an FDA-approved diagnosis have access to treatment, the SareptAssist Patient Assistance Program plays a crucial role in improving patient health outcomes.
Insurance requirements: Underinsured, Uninsured
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
ENROLLMENT FORMS ARE LOCATED AT VERY BOTTOM OF WEBPAGE. SELECT THE CORRECT ENROLLMENT FORM FOR THE MEDICATION
The PAP Program can help patients, who are uninsured or rendered uninsured and meet certain eligibility requirements
Patient may be responsible for additional costs associated with administration of the drug
HCP should complete and submit the SareptAssist START Form or the Sarepta Gene Therapy Enrollment Form (depending on the medication)
Fax completed form to 18006215203 or email to SareptAssist@Sarepta.com
Case Manager will call patient to discuss eligibility and go over next steps
For any questions, please call Call 1888SAREPTA (18887273782), Monday through Friday, 8:30am – 6:30pm ET
Other Programs

Assistance Fund: Duchenne Muscular Dystrophy

Commercially Insured
Medicare / Medicaid

NORD: Duchenne Muscular Dystrophy (Medical Assistance)

Underinsured
Uninsured
Other Tools for Exondys 51